Skip to content
RDL Network logo
P-051: Sustained bone marrow and imaging MRD negativity as indicators to discontinue lenalidomide maintenance after ASCT; preliminary results of a single-center prospective cohort study — Panagiotis Malandrakis (2022) | RDL Network